Active — Not RecruitingNot Applicable

Augmented Reality-Based Aromatherapy Education for Older Adults With Early-Stage Dementia in Taiwan

Taiwan300 participantsStarted 2025-05-23

Plain-language summary

This study evaluates an augmented reality (AR)-based aromatherapy education program designed for older adults with early-stage dementia in Taiwan. Participants are randomly assigned to either the intervention group, which receives AR-supported aromatherapy education sessions, or a comparison group receiving standard activities. The primary objective is to assess changes in neuropsychiatric symptoms and psychological well-being. Secondary outcomes include cognitive function and quality of life. The study aims to explore the feasibility and potential clinical benefits of integrating digital technology with non-pharmacological dementia care approaches.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 65 years * AD-8 score ≥ 2, indicating suspected cognitive impairment * Ability to communicate and complete study questionnaires * No significant visual, hearing, or olfactory impairments * Willingness to participate in AR-based intervention sessions Exclusion Criteria: * Diagnosed psychiatric disorder * Complex chronic physical diseases * Moderate to severe dementia * Neuropsychiatric Inventory Questionnaire (NPI-Q) symptom score \> 3

What they're measuring

Change in Neuropsychiatric Symptoms Measured by the Neuropsychiatric Inventory Questionnaire (NPI-Q)

Timeframe: Baseline, Week 4 (Post-Intervention), and Week 16 (Follow-up)

Trial details

NCT IDNCT07431164

SponsorNational Taiwan Normal University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-10-30

View on ClinicalTrials.gov More Dementia trials